Nordic Pharma Consulting ApS: Financial statements 2016
CVR: 37368598
Source: annual report 2016, Danish Business Authority
14/01/2016 – 31/12/2016
Nordic Pharma Consulting ApS (CVR 37368598) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 1,692,607 and a net result of DKK 619,789. Equity in the 2016 report amounted to DKK 669,789. The solvency ratio was 51%.
- Gross Profit
- DKK 1,692,607
- Profit/Loss
- DKK 619,789
- Equity
- DKK 669,789
- Total Assets
- DKK 1,313,357
Official annual report
Find more companies like Nordic Pharma Consulting ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of January 14, 2016, Thomas Bill Madsen is registered as adm. dir. of Nordic Pharma Consulting ApS.
As of January 14, 2016, Bill Holding ApS is registered as an owner of Nordic Pharma Consulting ApS with an ownership share of 50%.
Nordic Pharma Consulting ApS was founded on January 14, 2016.
About Nordic Pharma Consulting ApS
Nordic Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2016. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Bill Madsen and Ray David Sossna. The company is owned by Bill Holding ApS and by.david ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 15,902,080 and a net result of DKK 3,684,788 compared with DKK 2,966,376 the year before. Equity in the 2025 report amounted to DKK 4,487,385.